BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FABP1
,
G-protein-coupled receptor binding
,
Leukemia
,
Stem cell
,
Biofuel
,
Cisplatin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CCAR2;jsessionid=24CB290B2EB3B80B55F7C02B8FAE6717
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Testes
Pituitary gland
Tonsil
Prefrontal cortex
Globus pallidus
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
A novel form of Deleted in breast cancer 1 (DBC1) lacking the N-terminal domain does not bind SIRT1 …
Deleted in Breast Cancer 1 regulates cellular senescence during obesity.
Inflammation negatively regulates FOXP3 and regulatory T-cell function via DBC1.
DBC1 is involved in adipocyte inflammation and is a possible marker of human adipose tissue senescen…
Deleted in breast cancer 1 (DBC1) deficiency results in apoptosis of breast cancer cells through imp…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for CCAR2;jsessionid=24CB290B2EB3B80B55F7C02B8FAE6717
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ